Evidence map›Paper›PMID 40430968›Full record

ArticlePharmaceutics2025

Novel Drug-Drug Cocrystalline Forms of Carbamazepine with Sulfacetamide: Preparation, Characterization, and In Vitro/In Vivo Performance Evaluation.

Denis E Boycov, Ksenia V Drozd, Alex N Manin, Andrei V Churakov, Mikhail Yu Vlasov, Irina V Kachalkina, German L Perlovich

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Denis E BoycovG.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., Ivanovo 153045, Russia.ORCID 0000-0002-4118-3427
Ksenia V DrozdG.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., Ivanovo 153045, Russia.ORCID 0000-0001-9888-0648
Alex N ManinG.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., Ivanovo 153045, Russia.ORCID 0000-0002-7460-3109
Andrei V ChurakovInstitute of General and Inorganic Chemistry of the Russian Academy of Sciences, 31 Leninsky Prosp., Moscow 119991, Russia.ORCID 0000-0003-3336-4022
Mikhail Yu VlasovResearch Institute of Biotechnology "BioTech", Samara State Medical University of the Ministry of Health of the Russian Federation, 89 Chapayevskaya St., Samara 443099, Russia.
Irina V KachalkinaResearch Institute of Biotechnology "BioTech", Samara State Medical University of the Ministry of Health of the Russian Federation, 89 Chapayevskaya St., Samara 443099, Russia.
German L PerlovichG.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1 Akademicheskaya St., Ivanovo 153045, Russia.ORCID 0000-0002-6267-5244

Funding

Russian Science Foundation 22-13-00031-P
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

carbamazepinecocrystalcrystal structuredissolutionpermeabilitypharmacokineticsphase diagramstabilitysulfacetamide

Identifiers

PMID40430968
PMCPMC12115326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.